Sort   by:  
 Page size 
UnknownA Syd-1 homologue regulates pre- and postsynaptic maturation inDrosophila
Not available
S-JCBD-200908055 | bioimages
ProteomicsTargeted inhibition of human breast cancer cell lines selected as model systems of ERBB2-positive/EGFR high breast cancer [RPPA-SKBR3]
EGFR-inhibition is required for targeted therapies of ERBB2-positive/EGFR high breast cancer. Approximately 30% of human ERBB2-positive breast tumors also express EGFR. Three targeted therapeutics (erlotinib, pertuzumab, trastuzumab) and two ligands (EGF, HRG) were analyzed in all possible combinati...
ORGANISM(S): Homo sapiens 
2012-10-22 | E-GEOD-36326 | biostudies-arrayexpress
ProteomicsTargeted inhibition of human breast cancer cell lines selected as model systems of ERBB2-positive/EGFR high breast cancer [RPPA-Longterm]
EGFR-inhibition is required for targeted therapies of EGFR high/ERBB2 positive breast cancer. Approximately 30% of human ERBB2 positive breast tumors also express EGFR. Three therapeutics were analyzed in five combinations plus control. Each experiment was performed in three biological replicates. T...
ORGANISM(S): Homo sapiens 
2012-10-22 | E-GEOD-36325 | biostudies-arrayexpress
ProteomicsTargeted inhibition of human breast cancer cell lines selected as model systems of ERBB2-positive/EGFR high breast cancer [RPPA-HCC1954]
EGFR-inhibition is required for targeted therapies of ERBB2-positive/EGFR high breast cancer. Approximately 30% of human ERBB2-positive breast tumors also express EGFR. Three targeted therapeutics (erlotinib, pertuzumab, trastuzumab) and two ligands (EGF, HRG) were analyzed in all possible combinati...
ORGANISM(S): Homo sapiens 
2012-10-22 | E-GEOD-36324 | biostudies-arrayexpress
Sort   by:  
 Page size